Clinical Trial Update: Functional Improvement of Coronary Artery Narrowing by Cholesterol Reduction With a PCSK9 Antibody [NA]

View source ↗

Summary

Completed clinical trial evaluating whether lowering cholesterol with a PCSK9 antibody improves function in coronary artery narrowing. The update does not provi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis of the Coronary Artery
• Coronary Artery Disease

Drugs mentioned

• PCSK9 antibody

Snippet

Sponsor: Radboud University Medical Center | Conditions: Coronary Artery Disease, Atherosclerosis of Coronary Artery | NA | Status: COMPLETED